retatrutide glp-1 medication Extreme Side Effects Followed Overdose of Unapproved Weight-Loss Drug Next-Gen GLP-1 after Ozempic: Retatrutide

Weight loss compared to placebo was ~5% in RCTs

With the advent of GLP-1 mimetics like liraglutide and semaglutide, obese individuals now have access to approved alternatives for weight management beyond traditional methods, marking a significant shift in obesity treatment without the prerequisite of diabetes [1]

Those interested in berberine should discuss its use with their healthcare provider, particularly if they have diabetes, take other medications, or have cardiovascular disease, as professional guidance can help integrate supplements safely within an overall treatment plan while maintaining appropriate monitoring and medication management

Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of morbidity and mortality in T2D patients and is the largest contributor of direct and indirect costs of diabetes 1